Xiaochun Fei, [email protected]
These actions illustrate two important factors in controlling drug spend while providing access to the medications patients need, Carter said
This glucagon-like peptide 1 receptor agonist, or GLP-1 drug, was originally approved to treat type 2 diabetes and is now increasingly prescribed to treat obesity
Since then, a number of triple agonists have entered clinical development, with one in phase three clinical studies but have yet to reach the market (Capozzi, DiMarchi, Tschp)
If you have trouble reaching a site or keeping the pen steady, ask your provider or pharmacist to watch your technique or suggest an easier site
EASY TO CONSUME TABLETSConvenient tablet format suitable for regular nutritional supplementation as advised by healthcare professionals